Search results for "bacteri"

showing 10 items of 5466 documents

Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry

2022

Skin and soft tissue infections (SSTIs) represent a heterogenous group of pathological conditions involving the skin or the underlying subcutaneous tissues, fascia and muscle, characterised by a considerable variety of clinical presentations, severity and possible aetiological pathogens. Although previous analyses on restricted types of SSTIs and population have already been published, we conducted a large nationwide surveillance program on behalf of the Italian Society of Infectious and Tropical Diseases to assess the clinical and microbiological characteristics of the whole SSTI spectrum, from mild to severe life-threatening infections, in both inpatients and outpatients and their managem…

PharmacologyAdultRegistrieSoft Tissue InfectionsSoft Tissue Infections.SSTIComorbidityABSSSIregistryABSSSIs; SSTIs; registryABSSSIsAnti-Bacterial AgentsProspective StudieInfectious DiseasesOncologySSTIsItalyAnti-Bacterial AgentHumansPharmacology (medical)Prospective StudiesRegistriesHuman
researchProduct

Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models

2022

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer. The characteristic excessive stromatogenesis accompanying the growth of this tumor is believed to contribute to chemoresistance which, together with drug toxicity, results in poor clinical outcome. An increasing number of studies are showing that gut microbiota and their metabolites are implicated in cancer pathogenesis, progression and response to therapies. In this study we tested butyrate, a product of dietary fibers' bacterial fermentation, whose anticancer and anti-inflammatory functions are known. We provided in vitro evidence that, beside slowing proliferation, butyrate enhanced gemcitabine effectiveness against two hum…

PharmacologyBacteriaMicrobiotaPancreatic cancerGeneral MedicineSettore MED/08 - Anatomia PatologicaDeoxycytidineGemcitabinePancreatic NeoplasmsButyratesMiceCell Line TumorAnimalsGemcitabine responseCarcinoma Pancreatic DuctalBiomedicine & Pharmacotherapy
researchProduct

In-use physicochemical and microbiological stability of biological parenteral products

2015

Pharmaceutical scientists in the biotechnology industry have traditionally focused on achieving acceptable shelf lives of drug products in their original, unopened product unit configuration (e.g., two years stored at 2–8 °C). However, it is now clear that stability considerations extend beyond

PharmacologyBiological ProductsBacteriabusiness.industryChemistry PharmaceuticalDrug CompoundingHealth PolicyProteinsBiotechnologyPharmaceutical SolutionsDrug StabilityHumansInfusions ParenteralBusinessBiochemical engineeringProduct (category theory)Drug ContaminationDrug PackagingBiotechnology industryAmerican Journal of Health-System Pharmacy
researchProduct

Untersuchungen zur Frage des bakteriellen Inulin-Abbaues im menschlichen Darm

1950

Among the bacteria normally occurring in the intestine no races could be demonstrated that were capable of breaking down inuline. Among other bacteria, only pneumococci proved to be capable of breaking down inuline.

PharmacologyCellular and Molecular Neurosciencechemistry.chemical_compoundbiologyurogenital systemChemistryInulinMolecular MedicineCell Biologybiology.organism_classificationMolecular BiologyBacteriaMicrobiologyExperientia
researchProduct

Nanoparticles coated by chloramphenicol in hydrogels as a useful tool to increase the antibiotic release and antibacterial activity in dermal drug de…

2023

Abstract Background Nanocarriers for antibacterial drugs became hopeful tools against the increasing resistance of bacteria to antibiotics. This work focuses on a comprehensive study of the applicability and therapeutic suitability of dermal carbopol-based hydrogels containing chloramphenicol carried by various nanoparticles (AuNPs and SiNPs). Methods The different forms of carbopol-based drugs for dermal use were obtained. Five different concentrations of chloramphenicol and two types of nanoparticles (silica and gold) in carbopol-based ointments were tested. The influence of different carbopol formulations with nanocarriers on the rheological properties as well as the release profile of a…

PharmacologyChloramphenicolAntibioticsDrug deliveryBacteriostatic activityNanoparticlesGold nanoparticlesCarbopolRheological propertiesGeneral MedicineSilica nanoparticlesPharmacological Reports
researchProduct

Should continuous infusion of β‐lactam antibiotics be the first‐line approach?

1997

PharmacologyContinuous infusionbusiness.industryStaphylococcusFirst lineStreptococcusMicrobial Sensitivity TestsPharmacologyGram-Positive Bacteriabeta-LactamsAnti-Bacterial AgentsDrug Delivery SystemsInjections IntravenousAnimalsHumansMedicinePharmacology (medical)Infusions IntravenousbusinessEnterococcusGram-Positive Bacterial InfectionsBeta lactam antibioticsJournal of Clinical Pharmacy and Therapeutics
researchProduct

Nostotrebin 6 Related Cyclopentenediones and δ-Lactones with Broad Activity Spectrum Isolated from the Cultivation Medium of the Cyanobacterium Nosto…

2020

Cyanobacteria are an interesting source of biologically active natural products, especially chemically diverse and potent protease inhibitors. On our search for inhibitors of the trypanosomal cysteine protease rhodesain, we identified the homodimeric cyclopentenedione (CPD) nostotrebin 6 (1) and new related monomeric, dimeric, and higher oligomeric compounds as the active substances in the medium extract of Nostoc sp. CBT1153. The oligomeric compounds are composed of two core monomeric structures, a trisubstituted CPD or a trisubstituted unsaturated δ-lactone. Nostotrebin 6 thus far has been the only known cyanobacterial CPD. It has been found to be active in a broad variety of assays, indi…

PharmacologyCyanobacteriaNostocProteasebiologyStereochemistrymedicine.medical_treatmenteducationOrganic ChemistryPharmaceutical ScienceBiological activitybiology.organism_classificationCysteine proteaseAnalytical Chemistrychemistry.chemical_compoundMonomerComplementary and alternative medicinechemistryDrug DiscoverymedicineMolecular MedicineMoietyMoleculeJournal of Natural Products
researchProduct

Screening of cyanobacteria extracts for inhibitory activity against the cysteine protease rhodesain of Trypanosoma brucei

2016

PharmacologyCyanobacteriabiologyChemistryOrganic ChemistryPharmaceutical ScienceTrypanosoma bruceibiology.organism_classificationInhibitory postsynaptic potentialCysteine proteaseAnalytical ChemistryComplementary and alternative medicineBiochemistryDrug DiscoveryMolecular MedicinePlanta Medica
researchProduct

On the action of chromomycin on the eggs and embryos of Ciona intestinalis.

1964

E stata studiata l'azione della cromomicina sulle uova diCiona intestinalis (Ascidie) in diversi stadi di sviluppo. Essa non esercita alcun effetto sull'uovo vergine o appena fecondato; modifica invece notevolmente la morfogenesi se il trattamento e portato sulle uova in gastrulazione. I risultati vengono spiegati ammettendo che la cromomicina esercita la stessa azione che la actinomicina D e cioe inibisce la sintesi del MRNA.

PharmacologyEmbryo NonmammalianbiologyEmbryoCell BiologyIn Vitro Techniquesbiology.organism_classificationMolecular biologyAnti-Bacterial AgentsToxicologyCellular and Molecular NeuroscienceChordata NonvertebrateMolecular MedicineAnimalsRNACiona intestinalisFemaleMolecular BiologyCell DivisionOvumExperientia
researchProduct

Medicinal plants and antimicrobial activity.

2005

In the present paper, we analyze the past, present and future of medicinal plants, both as potential antimicrobial crude drugs as well as a source for natural compounds that act as new anti-infection agents. In the past few decades, the search for new anti-infection agents has occupied many research groups in the field of ethnopharmacology. When we reviewed the number of articles published on the antimicrobial activity of medicinal plants in PubMed during the period between 1966 and 1994, we found 115; however, in the following decade between 1995 and 2004, this number more than doubled to 307. In the studies themselves one finds a wide range of criteria. Many focus on determining the antim…

PharmacologyFloraPlants MedicinalTraditional medicinebusiness.industryPharmacognosyBiologySesquiterpeneAntimicrobialIsolation (microbiology)BiotechnologyAnti-Bacterial AgentsTerpenechemistry.chemical_compoundchemistryDrug DiscoveryEthnopharmacologyMedicine TraditionalbusinessMedicinal plantsAntibacterial agentJournal of ethnopharmacology
researchProduct